BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18186522)

  • 1. A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias.
    Goldaniga M; Ferrario A; Cortelazzo S; Guffanti A; Pavone E; Ambrosetti A; Marcheselli L; Rossi F; Luminari S; Rossi A; Cro L; Federico M; Lambertenghi Deliliers G; Baldini L
    Am J Hematol; 2008 May; 83(5):349-54. PubMed ID: 18186522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and laboratory approach to the CD5/CD10 negative B-cell chronic lymphoproliferative leukemias.
    Hanson CA; Morice WG
    Am J Hematol; 2008 May; 83(5):347-8. PubMed ID: 18383327
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
    Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
    Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia.
    Finn WG; Singleton TP; Schnitzer B; Ross CW; Stoolman LM
    Hum Pathol; 2001 Jan; 32(1):66-73. PubMed ID: 11172297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias.
    Cro L; Guffanti A; Colombi M; Cesana B; Grimoldi MG; Patriarca C; Goldaniga M; Neri A; Intini D; Cortelezzi A; Maiolo AT; Baldini L
    Leukemia; 2003 Jan; 17(1):125-32. PubMed ID: 12529669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
    Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
    Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
    Konoplev S; Medeiros LJ; Bueso-Ramos CE; Jorgensen JL; Lin P
    Am J Clin Pathol; 2005 Sep; 124(3):414-20. PubMed ID: 16191510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo CD5+ diffuse large B-cell lymphomas. A heterogeneous group containing an unusual form of splenic lymphoma.
    Kroft SH; Howard MS; Picker LJ; Ansari MQ; Aquino DB; McKenna RW
    Am J Clin Pathol; 2000 Oct; 114(4):523-33. PubMed ID: 11026098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomorphologic spectrum of small lymphocytic lymphoma in patients with an accelerated clinical course.
    Shin HJ; Caraway NP; Katz RL
    Cancer; 2003 Oct; 99(5):293-300. PubMed ID: 14579296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
    Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
    Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders.
    Pedreira CE; Costa ES; Almeida J; Fernandez C; Quijano S; Flores J; Barrena S; Lecrevisse Q; Van Dongen JJ; Orfao A;
    Cytometry A; 2008 Dec; 73A(12):1141-50. PubMed ID: 18836994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukaemia].
    Guillaume N; Alimardani G; Capiod JC; Claisse JF
    Ann Biol Clin (Paris); 2002; 60(6):673-81. PubMed ID: 12446231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance and independence of the immunologic, histological, and clinical features as prognostic factors in chronic lymphatic leukemia].
    Resegotti L; Levis A; Decrescenzo A; Ficara F; Pini M
    Haematologica; 1989 Oct; 74(5 Suppl):368-79. PubMed ID: 2512221
    [No Abstract]   [Full Text] [Related]  

  • 20. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.